Developer docs
API playgroundTry for free, no card

Search company profiles

A1M Pharma

Full company profile

uuid002aal1

Namestring
A1M Pharma
Legal namestring
A1M Pharma
Websiteurl
a1m.se
Company typeenum
Private
Founded yearint
2020
Descriptiontext

A1M Pharma, operating via the website a1m.se, is a Swedish-language informational content website that publishes educational articles about medications (Läkemedel), diseases (Sjukdomar), treatments, symptoms, drug side effects, natural remedies, and general health guidance. The site is organized into two main content categories and covers a broad range of health topics including dental health, fertility medications, nicotine alternatives, senior medication advice, skin care, and indoor environment-related illness. Content is produced under an 'admin' authorship with no editorial leadership, no medical advisory board, and no named contributors disclosed.

The platform is built on WordPress using the BlogJr theme by Shark Themes and functions as a static content/blog property with no e-commerce, no SaaS offering, no mobile application, and no proprietary technology stack. There are no APIs, SDKs, integrations, AI/ML features, patents, trademarks, or compliance certifications referenced in the source data. Distribution relies on organic SEO for Swedish-language search queries and a secondary Facebook page ('Om medicin') for social reach.

A material data conflict exists in the input: the firmographics header identifies the entity as a 2008-founded Lund-based pharmaceutical company focused on alpha-1-microglobulin therapeutics, while all detailed scraped records and the actual a1m.se website content describe an unrelated 2020-founded Swedish-language health information blog with no pharmaceutical products, no research pipeline, and no commercial offerings. The first-party website evidence and the more specific detailed sources are treated as authoritative for this analysis, but the entity identity itself constitutes a significant data-quality risk that should be resolved before any investment action.

Short descriptiontext

A1M Pharma (a1m.se) operates a Swedish-language WordPress blog publishing free educational articles on medications, diseases, treatments, and general health topics for Swedish-speaking consumers, with no commercial products or monetization model disclosed.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLund, Sweden
HQ citystring
Lund
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
health information blog, medication education content, disease treatment articles, Swedish health content, pharmaceutical information site
SIC code1 code
  • Books: Publishing Or Publishing & Printing2731
Product category
Health Information Content Publishing
Social media profiles2 records
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

A1M Pharma publishes and operates a1m.se, a Swedish-language informational blog that delivers free educational articles about medications, diseases, symptoms, drug side effects, treatments, natural remedies, dental health related to medications, fertility medications, nicotine alternatives, and senior medication advice. The site is organized into categories Läkemedel (Medications) and Sjukdomar (Diseases) and does not sell any products, subscriptions, or services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

A1M Pharma operates a single informational blog platform (a1m.se) that provides Swedish-language educational content about medications, diseases, health treatments, and wellness topics. The website functions as a content platform with articles covering various health categories including medications, diseases, symptoms, treatments, and side effects. It does not offer a SaaS product, application, or commercial service.

Product and service1 record
1A1M Pharma Informational Blog (a1m.se)
CategoryHealth Information Content Publishing
Description

An informational blog website providing free Swedish-language educational articles about medications, diseases, treatments, drug side effects, natural remedies, dental health related to medications, fertility treatments, nicotine products, and senior medication advice. Organized into categories Läkemedel (Medications) and Sjukdomar (Diseases). Targeted at Swedish-speaking general consumers seeking health information.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers8 records
1Apotea
TypeRegional player
Description

Sweden's largest online pharmacy, publishing medication-related content in Swedish. Comparable Swedish-language touchpoint for medication information, with a transactional pharmacy business layered on top.

TypeBroad incumbent
Description

Authoritative U.S. health information resource covering drugs, supplements, and diseases. Comparable in format and content scope (medication/disease education), though operates in English.

3Drugs.com
TypeDirect peer
Description

Consumer-facing medication information site providing drug side effects, interactions, and disease content. Directly comparable as a content-only medication reference platform targeting end consumers.

TypeRegional player
Description

Major Swedish pharmacy chain publishing medication-related content in Swedish. Adjacent comparable as a Swedish-language source of medication information, though primarily a retailer.

TypeBroad incumbent
Description

Sweden's official public health information service covering medications, diseases, symptoms, and treatments. Competes for the same Swedish-language health information queries with significantly higher authority and trust.

TypeDirect peer
Description

Swedish-language health information portal providing articles on medications, diseases, and treatments. Directly comparable as a content-first health information destination for the same Swedish-speaking audience.

7WebMD
TypeBroad incumbent
Description

Large-scale consumer health information site covering medications, conditions, and treatments. Comparable as a content-first medication/disease reference destination, though at much greater scale and primarily in English.

TypeBroad incumbent
Description

Swedish digital health platforms that combine content libraries on medications/conditions with telehealth services. Comparable as Swedish-language health information + service destinations.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

A1M Pharma

Health Information Content Publishinga1m.se

A1M Pharma (a1m.se) operates a Swedish-language WordPress blog publishing free educational articles on medications, diseases, treatments, and general health topics for Swedish-speaking consumers, with no commercial products or monetization model disclosed.

What A1M Pharma does

A1M Pharma, operating via the website a1m.se, is a Swedish-language informational content website that publishes educational articles about medications (Läkemedel), diseases (Sjukdomar), treatments, symptoms, drug side effects, natural remedies, and general health guidance. The site is organized into two main content categories and covers a broad range of health topics including dental health, fertility medications, nicotine alternatives, senior medication advice, skin care, and indoor environment-related illness. Content is produced under an 'admin' authorship with no editorial leadership, no medical advisory board, and no named contributors disclosed.

The platform is built on WordPress using the BlogJr theme by Shark Themes and functions as a static content/blog property with no e-commerce, no SaaS offering, no mobile application, and no proprietary technology stack. There are no APIs, SDKs, integrations, AI/ML features, patents, trademarks, or compliance certifications referenced in the source data. Distribution relies on organic SEO for Swedish-language search queries and a secondary Facebook page ('Om medicin') for social reach.

A material data conflict exists in the input: the firmographics header identifies the entity as a 2008-founded Lund-based pharmaceutical company focused on alpha-1-microglobulin therapeutics, while all detailed scraped records and the actual a1m.se website content describe an unrelated 2020-founded Swedish-language health information blog with no pharmaceutical products, no research pipeline, and no commercial offerings. The first-party website evidence and the more specific detailed sources are treated as authoritative for this analysis, but the entity identity itself constitutes a significant data-quality risk that should be resolved before any investment action.

A1M Pharma firmographics

Firmographics
Name
A1M Pharma
Legal name
A1M Pharma
Website
https://a1m.se
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
A1M Pharma (a1m.se) operates a Swedish-language WordPress blog publishing free educational articles on medications, diseases, treatments, and general health topics for Swedish-speaking consumers, with no commercial products or monetization model disclosed.
Ownership category
akta.pro rank

Where A1M Pharma is headquartered

Location

Headquarters

HQ city
Lund
HQ country
Sweden
HQ region
Europe

Markets served

A1M Pharma business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Distribution channels1 record

Marketing channels3 records

A1M Pharma product offering

Product offering

Core offering

A1M Pharma publishes and operates a1m.se, a Swedish-language informational blog that delivers free educational articles about medications, diseases, symptoms, drug side effects, treatments, natural remedies, dental health related to medications, fertility medications, nicotine alternatives, and senior medication advice. The site is organized into categories Läkemedel (Medications) and Sjukdomar (Diseases) and does not sell any products, subscriptions, or services.

Product overview

A1M Pharma operates a single informational blog platform (a1m.se) that provides Swedish-language educational content about medications, diseases, health treatments, and wellness topics. The website functions as a content platform with articles covering various health categories including medications, diseases, symptoms, treatments, and side effects. It does not offer a SaaS product, application, or commercial service.

Differentiator

Problem solved

Functional benefit

Products and services

  • A1M Pharma Informational Blog (a1m.se) An informational blog website providing free Swedish-language educational articles about medications, diseases, treatments, drug side effects, natural remedies, dental health related to medications, fertility treatments, nicotine products, and senior medication advice. Organized into categories Läkemedel (Medications) and Sjukdomar (Diseases). Targeted at Swedish-speaking general consumers seeking health information.

Companies that use A1M Pharma

Customer profile

Segments1 record

Ideal customer profiles1 record

A1M Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

A1M Pharma partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

A1M Pharma competitors and assessment

Company assessment

Regional players

  • Apotea: Sweden's largest online pharmacy, publishing medication-related content in Swedish. Comparable Swedish-language touchpoint for medication information, with a transactional pharmacy business layered on top.
  • Apotek Hjärtat: Major Swedish pharmacy chain publishing medication-related content in Swedish. Adjacent comparable as a Swedish-language source of medication information, though primarily a retailer.

Broad incumbents

  • MedlinePlus: Authoritative U.S. health information resource covering drugs, supplements, and diseases. Comparable in format and content scope (medication/disease education), though operates in English.
  • 1177 Vårdguiden: Sweden's official public health information service covering medications, diseases, symptoms, and treatments. Competes for the same Swedish-language health information queries with significantly higher authority and trust.
  • WebMD: Large-scale consumer health information site covering medications, conditions, and treatments. Comparable as a content-first medication/disease reference destination, though at much greater scale and primarily in English.
  • Kry / Doktor.se: Swedish digital health platforms that combine content libraries on medications/conditions with telehealth services. Comparable as Swedish-language health information + service destinations.

Direct peers

  • Drugs.com: Consumer-facing medication information site providing drug side effects, interactions, and disease content. Directly comparable as a content-only medication reference platform targeting end consumers.
  • Netdoktor: Swedish-language health information portal providing articles on medications, diseases, and treatments. Directly comparable as a content-first health information destination for the same Swedish-speaking audience.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

A1M Pharma social profiles

Digital presence

A1M Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

A1M Pharma leadership team

Management profile

Number of profiles

A1M Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

A1M Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about A1M Pharma

What does A1M Pharma do?

A1M Pharma publishes and operates a1m.se, a Swedish-language informational blog that delivers free educational articles about medications, diseases, symptoms, drug side effects, treatments, natural remedies, dental health related to medications, fertility medications, nicotine alternatives, and senior medication advice. The site is organized into categories Läkemedel (Medications) and Sjukdomar (Diseases) and does not sell any products, subscriptions, or services.

Is A1M Pharma a public or private company?

A1M Pharma is a private company. It is classified as unknown and is currently operating.

When was A1M Pharma founded?

A1M Pharma was founded in 2020. It employs 11 to 50 people.

Where is A1M Pharma based?

A1M Pharma is headquartered in Lund, Sweden, in the Europe region.

Who are A1M Pharma's main competitors?

Regional players on record are Apotea and Apotek Hjärtat. Broad incumbents are MedlinePlus, 1177 Vårdguiden, WebMD and Kry / Doktor.se. Direct peers are Drugs.com and Netdoktor.

Does A1M Pharma have an API?

No public API is recorded for A1M Pharma.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireCorrection of exchange notice (39/19) Trading in Unit Rights (UR) and Paid subscription units (BTU) in A1M Pharma AB (40/19)A1M Pharma AB's unit rights and paid subscription units will trade on First North from February 6, 2019. Unit rights trading ends February 18, 2019, while paid subscription units trade until further notice. The notice is distributed by Certified Adviser Erik Penser Bank.GlobeNewswireTrading in Unit Rights (UR) and Paid subscription units (BTU) in A1M Pharma AB (39/19)A1M Pharma AB's unit rights and paid subscription units will trade on First North from February 6, 2019, with unit rights trading until February 16, 2019. The instruments carry ISIN codes SE0012230712 and SE0012230720, respectively, and are listed on the STO segment.GlobeNewswireA1M Pharma AB receives observation status (419/18)Nasdaq Stockholm gave A1M Pharma AB observation status on November 21, 2018, citing material adverse uncertainty in its financial situation. The decision was made under First North rules, and the company published its Q3 2018 interim report that same day.GlobeNewswireTrading in subscription rights and paid subscription shares in A1M Pharma AB (publ) (66/18)A1M Pharma AB will trade subscription rights and paid subscription shares on First North starting March 7, 2018. Subscription rights trading ends March 19, 2018, while paid subscription shares trading continues until further notice. The instruments are listed with ISIN codes SE0010948364 and SE0010948372.GlobeNewswireNew equity right for trading, A1M Pharma AB (173/17)A1M Pharma AB's equity rights will trade on First North from June 20, 2017. The rights have a strike price of SEK 15.00 per share, with subscription periods in August-September and November-December 2017, and a last trading day of December 6, 2017.GlobeNewswireNew share for trading, A1M Pharma AB (publ) (171/17)A1M Pharma AB's shares will trade on First North from June 20, 2017, with 8,064,105 shares listed. The company is classified under Health Care, and trading is in SEK.